CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in CASI Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1
- −15 vs. Q4 2025
- Shares held
- 228
- −1.25M (−100.0%) vs. Q4 2025
- Total value
- $25
- −$1.06M (−100.0%) vs. Q4 2025
- New holders
- 0
- 1 more added
- Sold out
- 15
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.66M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $920.0K |
| Q4 2023 | 18 | $1.99M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 228 | $25 | 0.00% | +95+71.4% | Added |
| VR Adviser, LLC | 0 | $0 | 0.00% | −987,259−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −133,406−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −43,100−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −23,787−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −19,935−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −18,808−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,045−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −9,950−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −659−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −505−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −367−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −134−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Colonial Trust Co | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −5−100.0% | Sold out |